Patent Yard Sign in
Expired Canadian patentCanada

Transdermal delivery of highly ionized fat soluble drugs

CA 1252361 A · Owner: Alza Corporation · Inventors: Enscore, David J.; Gale, Robert M.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A medical device for the transdermal delivery of highly ionized fat insoluble drugs comprises an aqueous drug reservoir having a physiological pH, said reservoir preferably being a gel maintained in an impermeable receptacle by a highly permeable support member disposed between the gel and a permeable contact adhesive. A permeation enhancer reservoir delivers a permeation enhancer to the skin through the aqueous reservoir and through a permeation enhancer release rate controlling membrane which is permeable to the permeation enhancer and impermeable to the drug and water. In a preferred embodiment the permeation enhancer release rate controlling membrane forms at least a portion of said …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted April 11, 1989. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended April 11, 2006.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 2, 1986
GrantedApril 11, 1989
Term endedApril 11, 2006
Patent numberCA 1252361 A
Classification (IPC)A61M37/00 +1 more

Timeline

Timeline From CIPO dates

1987198919911993199519971999200120032005Application filedMay 2, 1986Patent grantedApril 11, 1989Term endedApril 11, 2006

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.